Barbara Friedland

2.4k total citations
60 papers, 1.5k citations indexed

About

Barbara Friedland is a scholar working on General Health Professions, Infectious Diseases and Microbiology. According to data from OpenAlex, Barbara Friedland has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in General Health Professions, 35 papers in Infectious Diseases and 21 papers in Microbiology. Recurrent topics in Barbara Friedland's work include Adolescent Sexual and Reproductive Health (37 papers), HIV/AIDS Research and Interventions (35 papers) and Reproductive tract infections research (21 papers). Barbara Friedland is often cited by papers focused on Adolescent Sexual and Reproductive Health (37 papers), HIV/AIDS Research and Interventions (35 papers) and Reproductive tract infections research (21 papers). Barbara Friedland collaborates with scholars based in United States, South Africa and India. Barbara Friedland's co-authors include Gita Ramjee, Khatija Ahmed, Marlena Plagianos, Kelly Blanchard, Thesla Palanee‐Phillips, Robin Maguire, Sumen Govender, Pekka Lähteenmäki, Lydia Altini and Janneke van de Wijgert and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Barbara Friedland

58 papers receiving 1.4k citations

Peers

Countries citing papers authored by Barbara Friedland

Since Specialization

Citations

This map shows the geographic impact of Barbara Friedland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Friedland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Friedland more than expected).

Fields of papers citing papers by Barbara Friedland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Friedland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Friedland. The network helps show where Barbara Friedland may publish in the future.

Co-authorship network of co-authors of Barbara Friedland

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Friedland. A scholar is included among the top collaborators of Barbara Friedland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Friedland. Barbara Friedland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial 2024 ·AIDS and Behavior ·Kenneth Ngure, Erica N. Browne, (unknown), Barbara Friedland, Ariane van der Straten, Thesla Palanee‐Phillips, (unknown), (unknown), (unknown), Bekezela Siziba, Lydia Soto-Torres, Gonasagrie Nair, Morgan Garcia, Connie Celum, Sarah T. Roberts	5
2	Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study) 2023 ·PLoS ONE ·Kenneth Ngure, Barbara Friedland, Daniel Szydlo, Sarah T. Roberts, Morgan Garcia, Lisa Levy, Carolyne A. Akello, Krishnaveni Reddy, Thesla Palanee‐Phillips, (unknown), Bekezela Siziba, Lydia Soto‐Torres, Sybil Hosek, Sharon L. Hillier, Gonasagrie Nair, Connie Celum, Ariane van der Straten	12
3	Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development 2023 ·AIDS and Behavior ·Barbara Friedland, Marlena Plagianos, (unknown), (unknown), (unknown), (unknown), Kate M. Guthrie, (unknown), Jim Pickett, Lisa B. Haddad	13
4	New approaches for developing biomarkers of hormonal contraceptive use 2023 ·Scientific Reports ·(unknown), Narender Kumar, Vivian Brache, Barbara Friedland, Marlena Plagianos, Shimin Zhang, Larisa Kizima, Leila Cochón, (unknown), Ann K. Blanc, Ruth Merkatz	1
5	To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa 2015 ·Culture Health & Sexuality ·Christine A. Kelly, Barbara Friedland, Neetha S. Morar, (unknown), Gita Ramjee, Mathildah Mpata Mokgatle, Khatija Ahmed	6
6	Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial 2015 ·AIDS and Behavior ·Barbara Friedland, Marie C. D. Stoner, Michelle M. Chau, Marlena Plagianos, Sumen Govender, Neetha S. Morar, Lydia Altini, (unknown), Khatija Ahmed, Gita Ramjee, (unknown), Robin Maguire, Pekka Lähteenmäki	9
7	Socioeconomic and behavioral factors influencing choice, adherence, and success of microbicide formulations 2014 ·UCL Discovery (University College London) ·Elizabeth E. Tolley, Barbara Friedland, Mitzy Gafos, K. Rivet Amico, Lut Van Damme, Cynthia Woodsong, Kathleen M. MacQueen, Leila E. Mansoor, Sheena McCormack	8
8	Engaging Male Partners in Women's Microbicide Use: Evidence from Clinical Trials and Implications for Future Research and Microbicide Introduction 2014 ·AIDS Research and Human Retroviruses ·Michele Lanham, Rose Wilcher, Elizabeth Montgomery, Robert Pool, Sidney Ruth Schuler, Rachel Lenzi, Barbara Friedland, Betty Njoroge, Elizabeth A. Bukusi, (unknown)	8
9	Enrollment of Adolescents Aged 16–17 Years Old in Microbicide Trials: An Evidence-Based Approach 2014 ·Journal of Adolescent Health ·Katie Schenk, Barbara Friedland, Michelle M. Chau, Marie C. D. Stoner, Marlena Plagianos, (unknown), Thesla Palanee‐Phillips, Khatija Ahmed, (unknown), (unknown), (unknown)	19
10	An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV‐based vaginal rings 2014 ·Journal of the International AIDS Society ·Kathleen M. MacQueen, Elizabeth E. Tolley, Derek H. Owen, K. Rivet Amico, Kathleen M. Morrow, Thomas R. Moench, David R. Friend, Barbara Friedland	21
11	Evaluation of 3 Approaches for Assessing Adherence to Vaginal Gel Application in Clinical Trials 2013 ·Sexually Transmitted Diseases ·Ariane van der Straten, Helen Cheng, Barbara Mensch, Barbara Friedland, (unknown), (unknown), (unknown), (unknown), Marla J. Keller, Betsy C. Herold, Mark H. Einstein	12
12	Use of the Dye Stain Assay and Ultraviolet Light Test for Assessing Vaginal Insertion of Placebo-Filled Applicators Before and After Sex 2013 ·Sexually Transmitted Diseases ·Marla J. Keller, (unknown), (unknown), Jennifer Walsh, Barbara Friedland, (unknown), (unknown), (unknown), Terri L. Cornelison, Betsy C. Herold, Mark H. Einstein	5
13	Characteristics of Female Sex Workers in Southern India Willing and Unwilling to Participate in a Placebo Gel Trial 2012 ·AIDS and Behavior ·Barbara Mensch, Barbara Friedland, (unknown), (unknown), Waimar Tun, Christine A. Kelly, Avina Sarna, Aylur K. Srikrishnan, Suniti Solomon	11
14	Acceptability of Carraguard Vaginal Microbicide Gel among HIV-Infected Women in Chiang Rai, Thailand 2011 ·PLoS ONE ·Sara Whitehead, Catherine McLean, Supaporn Chaikummao, Sarah Braunstein, (unknown), Janneke van de Wijgert, Philip A. Mock, Taweesap Siraprapasiri, Barbara Friedland, Peter H. Kilmarx, Lauri E. Markowitz	21
15	Hormonal contraception and the risk of HIV acquisition among women in South Africa 2011 ·AIDS ·Charles Morrison, (unknown), Cynthia Kwok, Pai‐Lien Chen, Janneke van de Wijgert, (unknown), Smruti Patel, Khatija Ahmed, Gita Ramjee, Barbara Friedland, (unknown)	67
16	Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa 2007 ·AIDS Research and Therapy ·Gita Ramjee, Neetha S. Morar, Sarah Braunstein, Barbara Friedland, Heidi E. Jones, Janneke van de Wijgert	41
17	Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa 2007 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Janneke van de Wijgert, Sarah Braunstein, Neetha S. Morar, Heidi E. Jones, Lorna Madurai, (unknown), (unknown), Jamila Aboobaker, (unknown), (unknown), Barbara Friedland, Clyde E. Hart, Gita Ramjee	36
18	Acceptability of Carraguard vaginal gel use among Thai couples 2006 ·AIDS ·Sara Whitehead, Peter H. Kilmarx, Kelly Blanchard, Chomnad Manopaiboon, Supaporn Chaikummao, Barbara Friedland, Jullapong Achalapong, (unknown), Philip A. Mock, Sombat Thanprasertsuk, Jordan W. Tappero	38
19	Acceptability and feasibility of Micralax® applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides 2001 ·AIDS ·Nicol Coetzee, Kelly Blanchard, Charlotte Ellertson, A A Hoosen, Barbara Friedland	31
20	Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA 2000 ·Reproductive Health Matters ·Christiana Coggins, Kelly Blanchard, Barbara Friedland	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact